Fantoni JC - Search Results

1

Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial).

Martinez Chanza N, Soukane L, Barthelemy P, Carnot A, Gil T, Casert V, Vanhaudenarde V, Sautois B, Staudacher L, Van den Brande J, Culine S, Seront E, Gizzi M, Albisinni S, Tricard T, Fantoni JC, Paesmans M, Caparica R, Roumeguere T, Awada A. Martinez Chanza N, et al. Among authors: fantoni jc. BMC Cancer. 2021 Dec 2;21(1):1292. doi: 10.1186/s12885-021-08990-3. BMC Cancer. 2021. PMID: 34856936 Free PMC article. Clinical Trial.

2

[Urachal cancers].

Peugniez C, Ghoneim T, Leroy X, Amela E, Fantoni JC, Culine S, Villers A, Adenis A. Peugniez C, et al. Among authors: fantoni jc. Bull Cancer. 2013 May;100(5):509-17. doi: 10.1684/bdc.2013.1718. Bull Cancer. 2013. PMID: 23501769 Review. French.

3

[Adjuvant chemotherapy for upper tract urothelial cancer: Level of evidence IA].

Pannier D, Fantoni JC, Turpin A, Penel N. Pannier D, et al. Among authors: fantoni jc. Bull Cancer. 2018 Oct;105(10):853-854. doi: 10.1016/j.bulcan.2018.07.017. Epub 2018 Sep 17. Bull Cancer. 2018. PMID: 30236478 French. No abstract available.

4

Active surveillance for non-muscle invasive bladder cancer.

Marcq G, Hénon F, Ouzaid I, Fantoni JC, Hermieu JF, Xylinas E. Marcq G, et al. Among authors: fantoni jc. Transl Androl Urol. 2019 Feb;8(1):54-60. doi: 10.21037/tau.2018.10.20. Transl Androl Urol. 2019. PMID: 30976569 Free PMC article. Review.

5

Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer.

Marcq G, Jarry E, Ouzaid I, Hermieu JF, Henon F, Fantoni JC, Xylinas E. Marcq G, et al. Among authors: fantoni jc. Ther Adv Urol. 2019 Jan 28;11:1756287218823678. doi: 10.1177/1756287218823678. eCollection 2019 Jan-Dec. Ther Adv Urol. 2019. PMID: 30728860 Free PMC article. Review.

6

Standard of care for adult Wilms tumor? From adult urologist to pediatric oncologist. A retrospective review.

Sudour-Bonnange H, Coulomb-Lherminé A, Fantoni JC, Escande A, Brisse HJ, Thebaud E, Verschuur A. Sudour-Bonnange H, et al. Among authors: fantoni jc. Bull Cancer. 2021 Feb;108(2):177-186. doi: 10.1016/j.bulcan.2020.09.007. Epub 2020 Oct 29. Bull Cancer. 2021. PMID: 33129487 Review.

7

Prognostic value of combined p53 and survivin in pT1G3 urothelial carcinoma of the bladder.

Gonzalez S, Aubert S, Kerdraon O, Haddad O, Fantoni JC, Biserte J, Leroy X. Gonzalez S, et al. Among authors: fantoni jc. Am J Clin Pathol. 2008 Feb;129(2):232-7. doi: 10.1309/2TY6GTV1GQ6B5ARM. Am J Clin Pathol. 2008. PMID: 18208803

8

Testicular natural killer T-cell lymphoma.

Ballereau C, Leroy X, Morschhauser F, Fantoni JC, Lemaitre L, Villers A, Biserte J. Ballereau C, et al. Among authors: fantoni jc. Int J Urol. 2005 Feb;12(2):223-4. doi: 10.1111/j.1442-2042.2005.01007.x. Int J Urol. 2005. PMID: 15733123

9

Low-risk prostate cancer selected for active surveillance with negative MRI at entry: can repeat biopsies at 1 year be avoided? A pilot study.

Olivier J, Kasivisvanathan V, Drumez E, Fantoni JC, Leroy X, Puech P, Villers A. Olivier J, et al. Among authors: fantoni jc. World J Urol. 2019 Feb;37(2):253-259. doi: 10.1007/s00345-018-2420-6. Epub 2018 Jul 23. World J Urol. 2019. PMID: 30039385

10

[Primary neuroectodermal tumour of the kidney invading the wall of the inferior vena cava. Surgical strategy].

Zini L, Nataf A, Fantoni JC, Villers A, Leroy X, Koussa M, Lemaitre L, Biserte J. Zini L, et al. Among authors: fantoni jc. Prog Urol. 2004 Sep;14(4):544-7. Prog Urol. 2004. PMID: 15776909 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters